Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free XMTR Stock Alerts

Xometry (XMTR) Financials

Xometry logo
$97.18 +1.92 (+2.02%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$97.11 -0.07 (-0.07%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Xometry

Annual Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -31 -40 -61 -79 -67 -50 -62
Consolidated Net Income / (Loss)		 -31 -31 -61 -79 -67 -50 -62
Net Income / (Loss) Continuing Operations		 -31 -31 -61 -79 -67 -50 -62
Total Pre-Tax Income 		-31 -31 -61 -79 -68 -50 -61
Total Operating Income		 -31 -29 -59 -77 -74 -56 -46
Total Gross Profit		 15 33 57 146 178 216 269
Total Revenue		 80 141 218 381 463 546 687
Operating Revenue		 80 141 218 381 463 546 687
Total Cost of Revenue		 65 108 161 235 285 330 418
Operating Cost of Revenue		 65 108 161 235 285 330 418
Total Operating Expenses		 45 63 116 223 252 272 314
Selling, General & Admin Expense		 8.02 12 35 58 71 65 72
Marketing Expense		 15 23 39 84 94 108 123
Research & Development Expense		 11 12 18 31 34 39 47
Other Operating Expenses / (Income)		 10 14 24 49 52 59 72
Impairment Charge		 1.72 1.59 0.00 0.82 0.40 0.08 0.05
Total Other Income / (Expense), net		 -0.45 -1.87 -2.70 -1.92 5.76 5.73 -16
Interest Expense		 0.24 1.09 0.85 4.42 4.78 4.75 4.91
Interest & Investment Income		 0.00 0.00 1.02 4.69 12 11 8.97
Other Income / (Expense), net		 -0.20 -0.78 -2.87 -2.18 -1.51 -0.76 -20
Income Tax Expense		 - 0.00 0.00 0.04 -0.35 -0.02 0.59
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 -0.00 0.02 0.01 -0.00 -0.01
Basic Earnings per Share		 ($4.88) ($5.32) ($4.66) ($3.36) ($1.41) ($1.03) ($1.22)
Weighted Average Basic Shares Outstanding		 6.35M 7.49M 52.64M 94.32M 47.91M 49.08M 50.81M
Diluted Earnings per Share		 ($4.88) ($5.32) ($4.66) ($3.36) ($1.41) ($1.03) ($1.22)
Weighted Average Diluted Shares Outstanding		 6.35M 7.49M 52.64M 94.32M 47.91M 49.08M 50.81M
Weighted Average Basic & Diluted Shares Outstanding		 6.35M 7.49M 26.32M 45.07M 48.58M 50.30M 51.82M

Quarterly Income Statements for Xometry

This table shows Xometry's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -11 -17 -14 -10 -9.89 -15 -26 -12 -8.63 -5.27 -5.31
Consolidated Net Income / (Loss)		 -11 -17 -14 -10 -9.90 -15 -26 -12 -8.64 -5.26 -5.31
Net Income / (Loss) Continuing Operations		 -11 -17 -14 -10 -9.90 -15 -26 -12 -8.64 -5.26 -5.31
Total Pre-Tax Income 		-11 -17 -14 -10 -9.94 -15 -26 -12 -8.02 -5.01 -4.96
Total Operating Income		 -13 -18 -15 -11 -12 -15 -10 -11 -8.78 -5.22 -5.55
Total Gross Profit		 49 48 53 56 59 56 65 72 75 78 87
Total Revenue		 128 123 133 142 149 151 163 181 192 205 229
Operating Revenue		 128 123 133 142 149 151 163 181 192 205 229
Total Cost of Revenue		 79 75 80 86 90 95 97 109 117 127 142
Operating Cost of Revenue		 79 75 80 86 90 95 97 109 117 127 142
Total Operating Expenses		 62 66 68 67 71 72 75 83 84 84 93
Selling, General & Admin Expense		 14 15 16 16 17 17 17 19 19 21 25
Marketing Expense		 25 27 27 27 27 26 30 33 34 32 34
Research & Development Expense		 8.89 9.59 10 9.34 10 11 11 13 12 11 13
Other Operating Expenses / (Income)		 13 14 14 15 16 17 18 18 19 20 21
Impairment Charge		 - - - 0.00 0.08 0.00 0.00 0.05 - 0.00 0.00
Total Other Income / (Expense), net		 1.43 1.25 1.58 1.31 1.59 0.32 -16 -0.56 0.75 0.21 0.59
Interest Expense		 1.19 1.19 1.19 1.19 1.19 1.19 1.18 1.28 1.26 1.26 1.26
Interest & Investment Income		 2.97 2.83 3.00 2.94 2.47 2.38 2.39 2.36 1.84 1.93 2.85
Other Income / (Expense), net		 -0.36 -0.39 -0.23 -0.44 0.31 -0.88 -17 -1.64 0.17 -0.46 -1.01
Income Tax Expense		 -0.56 0.00 -0.01 0.03 -0.04 0.00 -0.01 -0.02 0.61 0.25 0.35
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.00 0.01 -0.01 0.00 -0.01 0.00 -0.00 0.00 -0.00 0.01 -0.00
Basic Earnings per Share		 ($1.64) ($0.34) ($0.28) ($0.21) ($1.23) ($0.30) ($0.52) ($0.23) ($0.17) ($0.10) ($0.10)
Weighted Average Basic Shares Outstanding		 95.83M 48.58M 48.84M 49.28M 98.17M 50.34M 50.70M 50.92M 50.81M 51.91M 54.22M
Diluted Earnings per Share		 ($1.64) ($0.34) ($0.28) ($0.21) ($1.23) ($0.30) ($0.52) ($0.23) ($0.17) ($0.10) ($0.10)
Weighted Average Diluted Shares Outstanding		 95.83M 48.58M 48.84M 49.28M 98.17M 50.34M 50.70M 50.92M 50.81M 51.91M 54.22M
Weighted Average Basic & Diluted Shares Outstanding		 48.58M 46.12M 49.30M 49.56M 50.30M 50.68M 50.80M 51.25M 51.82M 52.60M 57.32M

Annual Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 25 20 26 -21 -12 -31 -7.24
Net Cash From Operating Activities		 -27 -22 -69 -63 -30 -15 6.09
Net Cash From Continuing Operating Activities		 -27 -22 -69 -63 -30 -15 6.09
Net Income / (Loss) Continuing Operations		 -31 -31 -61 -79 -67 -50 -62
Consolidated Net Income / (Loss)		 -31 -31 -61 -79 -67 -50 -62
Depreciation Expense		 1.85 3.12 3.60 7.82 11 13 19
Amortization Expense		 -0.04 0.00 0.00 1.72 1.86 1.86 2.10
Non-Cash Adjustments To Reconcile Net Income		 3.54 3.95 13 33 38 36 61
Changes in Operating Assets and Liabilities, net		 -1.48 1.97 -24 -26 -13 -15 -14
Net Cash From Investing Activities		 -2.35 6.67 -213 -239 17 -20 -17
Net Cash From Continuing Investing Activities		 -2.35 6.67 -213 -239 17 -20 -17
Purchase of Property, Plant & Equipment		 -2.69 -4.19 -6.26 -14 -18 -18 -30
Acquisitions		 -1.43 0.00 -175 0.00 -3.35 0.00 0.00
Purchase of Investments		 -29 -18 -267 -284 -12 -19 -8.54
Sale of Property, Plant & Equipment		 0.16 0.00 0.00 0.19 0.22 0.08 0.00
Sale and/or Maturity of Investments		 30 29 235 59 50 17 22
Net Cash From Financing Activities		 55 35 308 281 1.07 4.64 2.89
Net Cash From Continuing Financing Activities		 55 35 308 281 1.07 4.64 2.89
Repayment of Debt		 -0.50 -4.78 -16 -9.31 0.00 0.00 -225
Repurchase of Common Equity		 0.00 0.00 -3.68 0.00 0.00 0.00 -8.08
Issuance of Debt		 0.00 8.78 0.00 288 0.00 0.00 250
Other Financing Activities, net		 0.29 0.51 2.32 2.78 1.07 4.64 -14
Effect of Exchange Rate Changes		 - -0.13 -0.06 -0.37 -0.23 -0.27 0.42
Cash Interest Paid		 1.11 1.27 0.91 1.41 2.88 2.88 3.55

Quarterly Cash Flow Statements for Xometry

This table details how cash moves in and out of Xometry's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 9.05 -7.72 -24 -4.64 4.80 -6.73 1.24 4.09 -5.85 6.05 0.71
Net Cash From Operating Activities		 -1.29 -12 -9.10 -3.63 9.09 -3.69 -0.43 5.79 4.41 15 2.92
Net Cash From Continuing Operating Activities		 -1.29 -12 -9.10 -3.63 9.09 -3.69 -0.46 5.79 4.41 15 2.92
Net Income / (Loss) Continuing Operations		 -11 -17 -14 -10 -9.90 -15 -26 -12 -8.64 -5.26 -5.31
Consolidated Net Income / (Loss)		 -11 -17 -14 -10 -9.90 -15 -26 -12 -8.64 -5.26 -5.31
Depreciation Expense		 2.80 3.15 3.26 3.21 3.39 4.25 4.50 5.00 5.01 4.93 5.84
Amortization Expense		 0.46 0.46 0.47 0.46 0.47 0.47 0.47 0.59 0.57 0.57 0.57
Non-Cash Adjustments To Reconcile Net Income		 7.42 7.38 9.58 8.44 10 8.84 26 13 13 9.62 14
Changes in Operating Assets and Liabilities, net		 -1.42 -6.13 -8.70 -5.55 5.01 -2.16 -5.01 -1.05 -5.44 4.76 -12
Net Cash From Investing Activities		 11 2.93 -15 -2.59 -5.45 -3.69 -0.15 -2.15 -11 -9.32 -305
Net Cash From Continuing Investing Activities		 11 2.93 -15 -2.59 -5.45 -3.69 -0.15 -2.15 -11 -9.32 -305
Purchase of Property, Plant & Equipment		 -6.42 -4.35 -4.40 -4.81 -4.54 -5.50 -6.96 -7.45 -10 -11 -13
Purchase of Investments		 -2.95 -2.73 -11 -2.77 -2.50 -2.27 -2.17 -2.13 -1.97 -12 -314
Sale and/or Maturity of Investments		 20 10 0.01 4.99 1.59 4.08 8.98 7.43 1.59 14 22
Net Cash From Financing Activities		 -0.36 1.23 0.56 1.42 1.42 0.51 1.54 0.46 0.38 0.83 303
Net Cash From Continuing Financing Activities		 -0.36 1.23 0.56 1.42 1.42 0.51 1.54 0.46 0.38 0.83 303
Other Financing Activities, net		 -0.36 1.23 0.56 1.42 1.42 0.51 -17 1.29 0.38 0.83 5.07
Effect of Exchange Rate Changes		 0.08 -0.15 -0.02 0.17 -0.26 0.14 0.28 -0.01 0.01 -0.08 0.05
Cash Interest Paid		 - 1.44 - 1.44 - 1.44 0.73 0.43 0.95 0.43 0.94
Cash Income Taxes Paid		 - - - - - 0.00 - - - 0.23 0.34

Annual Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 89 503 734 707 680 704
Total Current Assets		 78 163 387 356 328 335
Cash & Equivalents		 60 86 66 53 22 15
Short-Term Investments		 0.00 30 254 215 218 204
Accounts Receivable		 15 32 49 70 74 97
Inventories, net		 2.29 2.03 1.57 2.89 3.92 3.92
Prepaid Expenses		 0.91 6.66 7.59 5.57 4.95 7.26
Other Current Assets		 0.00 5.58 9.37 8.90 4.87 6.95
Plant, Property, & Equipment, net		 6.11 10 19 36 45 61
Total Noncurrent Assets		 5.20 329 328 316 308 308
Long-Term Investments		 0.00 4.20 4.07 4.11 4.07 4.07
Goodwill		 0.83 255 258 263 263 264
Intangible Assets		 1.65 42 39 36 32 29
Other Noncurrent Operating Assets		 2.71 28 26 13 8.87 12
Total Liabilities & Shareholders' Equity		 89 503 734 707 680 704
Total Liabilities		 39 77 362 377 365 427
Total Current Liabilities		 38 57 64 83 75 89
Short-Term Debt		 16 - - - - 0.00
Accounts Payable		 5.64 13 12 44 35 45
Accrued Expenses		 14 31 33 23 24 32
Current Deferred Revenue		 - 7.86 8.73 - 7.95 10
Current Deferred & Payable Income Tax Liabilities		 - 0.00 3.96 2.48 0.98 0.27
Other Current Liabilities		 3.38 5.55 5.47 14 6.44 2.07
Total Noncurrent Liabilities		 1.12 20 298 294 290 338
Long-Term Debt		 - 0.00 280 282 284 328
Noncurrent Deferred & Payable Income Tax Liabilities		 - 0.02 0.43 0.28 0.23 0.15
Other Noncurrent Operating Liabilities		 1.12 19 18 12 5.89 10
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -111 425 372 330 316 277
Total Preferred & Common Equity		 -111 424 371 329 314 276
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -111 424 371 329 314 276
Common Stock		 0.50 598 623 648 685 711
Retained Earnings		 -112 -173 -252 -320 -370 -432
Treasury Stock		 - - - - 0.00 -8.08
Accumulated Other Comprehensive Income / (Loss)		 0.21 0.15 0.03 0.86 -0.33 4.77
Noncontrolling Interest		 0.00 1.03 1.09 1.12 1.14 1.14

Quarterly Balance Sheets for Xometry

This table presents Xometry's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 725 708 701 692 679 678 690 687 699 740 1,058
Total Current Assets		 373 365 357 341 327 326 335 329 341 364 672
Cash & Equivalents		 40 57 44 46 22 17 16 17 21 21 22
Short-Term Investments		 256 229 232 208 219 217 216 209 204 203 495
Accounts Receivable		 52 58 64 69 71 79 86 87 99 120 130
Inventories, net		 1.44 1.34 1.31 2.89 2.87 3.50 4.03 4.63 4.24 3.60 3.88
Prepaid Expenses		 7.06 5.83 4.90 6.00 6.06 4.79 6.49 5.12 5.90 7.04 8.19
Other Current Assets		 16 14 10 9.37 6.51 4.86 7.19 6.09 7.55 9.70 13
Plant, Property, & Equipment, net		 22 24 26 38 40 42 47 51 55 69 80
Total Noncurrent Assets		 330 320 318 314 312 310 308 307 303 307 306
Long-Term Investments		 4.13 4.27 4.21 4.21 4.14 4.21 4.07 4.09 4.21 4.12 4.17
Goodwill		 262 263 263 263 263 263 263 264 264 264 263
Intangible Assets		 39 38 37 35 34 33 31 30 29 28 27
Other Noncurrent Operating Assets		 25 15 14 12 11 9.98 9.92 9.13 5.79 12 11
Total Liabilities & Shareholders' Equity		 725 708 701 692 679 678 690 687 699 740 1,058
Total Liabilities		 362 366 364 371 362 362 379 416 426 457 462
Total Current Liabilities		 65 69 68 79 71 71 89 84 94 204 209
Short-Term Debt		 - - - - - - - - - 85 85
Accounts Payable		 12 13 13 14 10 6.37 50 42 46 62 71
Accrued Expenses		 32 37 35 46 43 49 23 27 33 42 37
Current Deferred Revenue		 9.97 10.00 9.66 9.61 9.05 8.30 9.91 10 11 12 14
Current Deferred & Payable Income Tax Liabilities		 4.11 2.80 2.96 2.21 1.33 0.86 0.89 0.87 0.73 0.28 0.27
Other Current Liabilities		 6.26 6.50 6.74 6.73 6.66 6.64 5.29 4.18 2.55 2.40 2.52
Total Noncurrent Liabilities		 298 297 296 292 291 291 290 331 332 253 252
Long-Term Debt		 280 281 281 282 283 283 284 326 327 243 243
Noncurrent Deferred & Payable Income Tax Liabilities		 0.41 0.39 0.36 0.28 0.26 0.25 0.23 0.21 0.19 0.15 0.13
Other Noncurrent Operating Liabilities		 17 16 14 9.63 8.17 7.55 5.33 4.90 4.51 9.80 9.08
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 362 342 337 322 317 316 311 272 273 283 596
Total Preferred & Common Equity		 361 341 336 320 316 315 310 270 272 282 595
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 361 341 336 320 316 315 310 270 272 282 595
Common Stock		 629 635 642 657 666 674 694 686 699 723 1,041
Retained Earnings		 -268 -294 -306 -336 -350 -360 -385 -412 -423 -437 -443
Treasury Stock		 - - - - - - - -8.08 -8.08 -8.08 -8.08
Accumulated Other Comprehensive Income / (Loss)		 0.16 0.36 0.44 0.38 0.46 1.28 1.21 4.28 4.45 4.08 4.20
Noncontrolling Interest		 1.10 1.11 1.14 1.15 1.15 1.13 1.13 1.12 1.13 1.15 1.15

Annual Metrics And Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 76.26% 54.40% 74.47% 21.65% 17.72% 25.87%
EBITDA Growth		 0.00% 7.14% -115.64% -20.33% 10.39% 32.73% -5.57%
EBIT Growth		 0.00% 2.46% -105.20% -28.79% 5.28% 24.21% -14.62%
NOPAT Growth		 0.00% 4.36% -100.87% -31.36% 4.56% 23.69% 18.94%
Net Income Growth		 0.00% -0.29% -97.46% -28.77% 14.65% 25.29% -22.51%
EPS Growth		 0.00% -9.02% 12.41% 27.90% 16.07% 26.95% -18.45%
Operating Cash Flow Growth		 0.00% 18.71% -210.99% 8.74% 52.25% 48.51% 139.56%
Free Cash Flow Firm Growth		 0.00% 0.00% -1,219.27% 77.19% 19.35% 11.60% -4.06%
Invested Capital Growth		 0.00% 0.00% 5,600.13% 7.77% 3.38% 4.72% 7.24%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 8.85% 6.94% 3.89% 6.82%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -3.09% 19.96% 5.13% 8.90%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -4.44% 16.55% 2.87% 3.85%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -6.59% 16.75% 1.78% 5.69%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -4.71% 20.04% 1.29% 2.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -27.27% 18.02% 16.60% 46.49%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -62.21% 18.43% 34.55% 40.29% -43.43%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 13.27% 13.65% -31.43%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.40% 0.62% -1.65% 2.62%
Profitability Metrics		 - - - - - - -
Gross Margin		 18.37% 23.54% 26.17% 38.33% 38.47% 39.53% 39.14%
EBITDA Margin		 -36.08% -19.01% -26.54% -18.31% -13.48% -7.71% -6.46%
Operating Margin		 -38.08% -20.66% -26.88% -20.24% -15.88% -10.29% -6.63%
EBIT Margin		 -38.33% -21.21% -28.19% -20.81% -16.20% -10.43% -9.50%
Profit (Net Income) Margin		 -38.63% -21.98% -28.11% -20.75% -14.56% -9.24% -8.99%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.05% 99.48% 99.96% 100.96%
Interest Burden Percent		 100.78% 103.63% 99.72% 99.66% 90.32% 88.61% 93.77%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -765.53% -26.51% -17.06% -15.43% -11.32% -8.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -717.33% -1.91% 13.43% 76.54% -56.98% -50.15%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 639.85% 0.66% -2.77% -3.78% -4.29% -12.20%
Return on Equity (ROE)		 0.00% -125.69% -25.85% -19.83% -19.21% -15.60% -20.85%
Cash Return on Invested Capital (CROIC)		 0.00% -965.53% -219.62% -24.53% -18.75% -15.93% -15.64%
Operating Return on Assets (OROA)		 0.00% -33.72% -20.81% -12.82% -10.42% -8.20% -9.43%
Return on Assets (ROA)		 0.00% -34.94% -20.75% -12.78% -9.36% -7.27% -8.92%
Return on Common Equity (ROCE)		 0.00% 282.68% -17.04% -19.78% -19.15% -15.55% -20.77%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 27.94% -14.46% -21.32% -20.49% -16.03% 0.00%
Net Operating Profit after Tax (NOPAT)		 -21 -20 -41 -54 -52 -39 -32
NOPAT Margin		 -26.65% -14.46% -18.82% -14.17% -11.11% -7.20% -4.64%
Net Nonoperating Expense Percent (NNEP)		 0.00% -48.20% -24.60% -30.49% -91.97% 45.67% 41.50%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -8.28% -8.41% -6.56% -5.27%
Cost of Revenue to Revenue		 81.63% 76.46% 73.83% 61.67% 61.53% 60.47% 60.86%
SG&A Expenses to Revenue		 9.99% 8.52% 16.00% 15.29% 15.30% 11.91% 10.53%
R&D to Revenue		 13.26% 8.62% 8.14% 8.14% 7.44% 7.21% 6.81%
Operating Expenses to Revenue		 56.45% 44.20% 53.05% 58.56% 54.34% 49.82% 45.77%
Earnings before Interest and Taxes (EBIT)		 -31 -30 -62 -79 -75 -57 -65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -29 -27 -58 -70 -62 -42 -44
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 5.04 3.89 4.95 6.72 11.06
Price to Tangible Book Value (P/TBV)		 0.00 0.00 16.71 19.68 53.24 107.72 0.00
Price to Revenue (P/Rev)		 3.77 2.14 9.80 3.79 3.52 3.88 4.44
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 78.44 6.63 4.27 4.83 6.07 8.28
Enterprise Value to Revenue (EV/Rev)		 0.00 2.96 9.25 3.68 3.54 3.95 4.59
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 518.10
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 0.32 0.00 0.75 0.85 0.90 1.18
Long-Term Debt to Equity		 0.00 0.00 0.00 0.75 0.85 0.90 1.18
Financial Leverage		 0.00 -0.89 -0.35 -0.21 -0.05 0.08 0.24
Leverage Ratio		 0.00 1.80 1.25 1.55 2.05 2.15 2.34
Compound Leverage Factor		 0.00 1.86 1.24 1.55 1.85 1.90 2.19
Debt to Total Capital		 0.00% 24.15% 0.00% 42.95% 46.03% 47.33% 54.20%
Short-Term Debt to Total Capital		 0.00% 24.15% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 42.95% 46.03% 47.33% 54.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 246.43% 0.24% 0.17% 0.18% 0.19% 0.19%
Common Equity to Total Capital		 0.00% -170.58% 99.76% 56.88% 53.79% 52.48% 45.61%
Debt to EBITDA		 0.00 -0.59 0.00 -4.01 -4.51 -6.75 -7.38
Net Debt to EBITDA		 0.00 1.64 0.00 0.63 -0.14 -0.95 -2.35
Long-Term Debt to EBITDA		 0.00 0.00 0.00 -4.01 -4.51 -6.75 -7.38
Debt to NOPAT		 0.00 -0.77 0.00 -5.19 -5.47 -7.22 -10.28
Net Debt to NOPAT		 0.00 2.16 0.00 0.81 -0.17 -1.01 -3.27
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -5.19 -5.47 -7.22 -10.28
Altman Z-Score		 0.00 3.84 16.45 2.60 2.73 3.69 4.51
Noncontrolling Interest Sharing Ratio		 0.00% 324.91% 34.06% 0.27% 0.31% 0.35% 0.38%
Liquidity Ratios		 - - - - - - -
Current Ratio		 0.00 2.02 2.87 6.05 4.28 4.38 3.76
Quick Ratio		 0.00 1.94 2.62 5.76 4.07 4.20 3.56
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -26 -340 -78 -63 -55 -58
Operating Cash Flow to CapEx		 -1,068.75% -526.23% -1,095.03% -464.86% -163.59% -85.38% 20.17%
Free Cash Flow to Firm to Interest Expense		 0.00 -23.69 -399.41 -17.57 -13.08 -11.64 -11.73
Operating Cash Flow to Interest Expense		 -112.55 -20.25 -80.48 -14.16 -6.25 -3.24 1.24
Operating Cash Flow Less CapEx to Interest Expense		 -123.08 -24.09 -87.83 -17.21 -10.06 -7.03 -4.91
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 1.59 0.74 0.62 0.64 0.79 0.99
Accounts Receivable Turnover		 0.00 9.70 9.29 9.32 7.76 7.57 8.02
Inventory Turnover		 0.00 47.13 74.51 130.37 127.98 97.03 106.71
Fixed Asset Turnover		 0.00 23.13 26.63 25.94 16.94 13.56 13.02
Accounts Payable Turnover		 0.00 19.17 17.56 18.68 10.13 8.36 10.49
Days Sales Outstanding (DSO)		 0.00 37.62 39.29 39.14 47.01 48.19 45.54
Days Inventory Outstanding (DIO)		 0.00 7.74 4.90 2.80 2.85 3.76 3.42
Days Payable Outstanding (DPO)		 0.00 19.04 20.78 19.54 36.04 43.65 34.78
Cash Conversion Cycle (CCC)		 0.00 26.32 23.40 22.40 13.82 8.31 14.18
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 5.34 305 328 339 355 381
Invested Capital Turnover		 0.00 52.93 1.41 1.20 1.39 1.57 1.86
Increase / (Decrease) in Invested Capital		 0.00 5.34 299 24 11 16 26
Enterprise Value (EV)		 0.00 419 2,020 1,400 1,640 2,155 3,153
Market Capitalization		 303 303 2,139 1,443 1,630 2,114 3,048
Book Value per Share		 $0.00 ($14.85) $10.17 $8.28 $7.25 $6.34 $5.38
Tangible Book Value per Share		 $0.00 ($15.18) $3.07 $1.64 $0.67 $0.40 ($0.33)
Total Capital		 0.00 65 425 652 612 599 604
Total Debt		 0.00 16 0.00 280 282 284 328
Total Long-Term Debt		 0.00 0.00 0.00 280 282 284 328
Net Debt		 0.00 -44 -121 -44 8.88 40 104
Capital Expenditures (CapEx)		 2.54 4.19 6.26 13 18 18 30
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -4.85 -10 3.79 4.26 13 27
Debt-free Net Working Capital (DFNWC)		 0.00 55 106 323 273 253 246
Net Working Capital (NWC)		 0.00 39 106 323 273 253 246
Net Nonoperating Expense (NNE)		 9.61 11 20 25 16 11 30
Net Nonoperating Obligations (NNO)		 0.00 -44 -121 -44 8.88 40 104
Total Depreciation and Amortization (D&A)		 1.81 3.12 3.60 9.54 13 15 21
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -3.43% -4.73% 0.99% 0.92% 2.37% 3.87%
Debt-free Net Working Capital to Revenue		 0.00% 38.91% 48.73% 84.85% 58.92% 46.33% 35.78%
Net Working Capital to Revenue		 0.00% 27.77% 48.73% 84.85% 58.92% 46.33% 35.78%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($2.33) ($1.61) ($2.82) ($2.06) ($1.22)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 44.16M 47.16M 95.83M 98.17M 50.81M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($2.33) ($1.61) ($2.82) ($2.06) ($1.22)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 44.16M 47.16M 95.83M 98.17M 50.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($2.33) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 26.32M 45.07M 48.58M 50.30M 51.82M
Normalized Net Operating Profit after Tax (NOPAT)		 -20 -19 -41 -53 -51 -39 -32
Normalized NOPAT Margin		 -25.15% -13.67% -18.82% -14.02% -11.05% -7.19% -4.64%
Pre Tax Income Margin		 -38.63% -21.98% -28.11% -20.74% -14.63% -9.24% -8.91%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 -127.61 -27.54 -72.24 -17.94 -15.70 -11.98 -13.29
NOPAT to Interest Expense		 -88.73 -18.78 -48.22 -12.21 -10.77 -8.27 -6.49
EBIT Less CapEx to Interest Expense		 -138.14 -31.39 -79.59 -20.99 -19.51 -15.77 -19.44
NOPAT Less CapEx to Interest Expense		 -99.26 -22.63 -55.57 -15.26 -14.58 -12.06 -12.64
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% -28.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -28.31% -5.99% 0.00% 0.00% 0.00% -13.09%

Quarterly Metrics And Ratios for Xometry

This table displays calculated financial ratios and metrics derived from Xometry's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 51,824,424.00 52,598,798.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 51,824,424.00 52,598,798.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.10 -0.10
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 30.67% 16.49% 19.45% 19.15% 15.92% 23.05% 22.59% 27.54% 29.52% 35.88% 41.05%
EBITDA Growth		 61.81% 12.61% 9.86% 64.18% 23.58% 20.97% -92.27% 13.86% 58.93% 98.43% 99.35%
EBIT Growth		 53.60% 7.72% 45.78% 13.55% 13.02% 10.81% -78.17% -6.46% 23.29% 65.07% 76.30%
NOPAT Growth		 54.13% 9.75% 45.50% 13.00% 8.11% 13.81% 32.70% 3.68% 23.83% 66.08% 46.11%
Net Income Growth		 61.57% 9.48% 48.40% 15.08% 6.23% 9.20% -92.91% -13.71% 12.71% 65.12% 79.90%
EPS Growth		 27.43% 10.53% 49.09% 16.00% 25.00% 11.76% -85.71% -9.52% 15.00% 66.67% 80.77%
Operating Cash Flow Growth		 92.42% 28.69% -47.94% 39.19% 802.09% 68.54% 95.31% 259.38% -51.44% 496.18% 783.61%
Free Cash Flow Firm Growth		 53.57% 60.70% 1.42% -64.18% -21.26% -54.69% 36.51% 44.65% -32.25% -10.32% -93.44%
Invested Capital Growth		 3.38% 1.00% 6.53% 7.13% 4.72% 4.00% 3.78% 2.77% 7.24% 6.53% 9.77%
Revenue Q/Q Growth		 7.75% -4.26% 8.07% 6.87% 4.83% 1.63% 7.67% 11.18% 6.46% 6.62% 11.77%
EBITDA Q/Q Growth		 58.18% -51.87% 19.33% 30.10% 10.77% -57.07% -96.26% 68.68% 57.45% 93.98% 19.23%
EBIT Q/Q Growth		 6.52% -41.49% 14.92% 23.17% 5.95% -45.08% -69.97% 54.10% 32.23% 33.93% -15.31%
NOPAT Q/Q Growth		 4.99% -42.41% 14.38% 24.91% -0.36% -33.58% 33.14% -7.47% 20.64% 40.52% -6.23%
Net Income Q/Q Growth		 12.13% -57.34% 17.47% 25.58% 2.97% -52.34% -75.36% 56.13% 25.52% 39.12% -1.05%
EPS Q/Q Growth		 -556.00% 79.27% 17.65% 25.00% -485.71% 75.61% -73.33% 55.77% 26.09% 41.18% 0.00%
Operating Cash Flow Q/Q Growth		 78.35% -806.80% 22.44% 60.07% 350.00% -140.63% 88.43% 1,456.44% -23.83% 231.44% -80.04%
Free Cash Flow Firm Q/Q Growth		 -1.63% 19.92% -103.92% 1.07% 24.93% -2.15% 16.30% 13.75% -79.34% 14.79% -46.77%
Invested Capital Q/Q Growth		 0.62% 1.93% 2.54% 1.87% -1.65% 1.22% 2.32% 0.89% 2.62% 0.56% 5.44%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 38.30% 39.04% 39.88% 39.40% 39.73% 37.31% 40.10% 39.86% 39.10% 38.26% 38.01%
EBITDA Margin		 -7.52% -11.92% -8.90% -5.82% -4.95% -7.66% -13.96% -3.93% -1.57% -0.09% -0.06%
Operating Margin		 -9.79% -14.55% -11.53% -8.10% -7.76% -10.19% -6.33% -6.12% -4.56% -2.54% -2.42%
EBIT Margin		 -10.06% -14.87% -11.71% -8.42% -7.55% -10.78% -17.01% -7.02% -4.47% -2.77% -2.86%
Profit (Net Income) Margin		 -8.24% -13.53% -10.34% -7.20% -6.66% -9.99% -16.26% -6.42% -4.49% -2.56% -2.32%
Tax Burden Percent		 94.95% 100.00% 99.93% 100.30% 99.59% 100.00% 99.97% 99.85% 107.65% 104.95% 107.14%
Interest Burden Percent		 86.20% 91.01% 88.35% 85.27% 88.60% 92.66% 95.62% 91.48% 93.27% 88.16% 75.68%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -9.51% -14.23% -11.80% -8.53% -8.53% -11.61% -7.40% -7.52% -5.95% -3.55% -3.54%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.72% -204.15% -33.18% -18.09% -16.06% -23.41% -36.08% -12.90% -9.42% -5.71% -0.55%
Return on Net Nonoperating Assets (RNNOA)		 -0.04% -1.29% -1.41% -1.25% -1.21% -2.70% -8.22% -3.13% -2.29% -1.43% 0.06%
Return on Equity (ROE)		 -9.55% -15.52% -13.21% -9.78% -9.74% -14.31% -15.63% -10.65% -8.24% -4.98% -3.48%
Cash Return on Invested Capital (CROIC)		 -18.75% -15.56% -18.31% -18.35% -15.93% -14.57% -13.14% -11.96% -15.64% -12.99% -14.87%
Operating Return on Assets (OROA)		 -6.47% -10.09% -8.48% -6.41% -5.94% -8.95% -15.04% -6.56% -4.44% -2.87% -2.65%
Return on Assets (ROA)		 -5.29% -9.18% -7.49% -5.48% -5.24% -8.29% -14.38% -5.99% -4.46% -2.66% -2.15%
Return on Common Equity (ROCE)		 -9.52% -15.47% -13.16% -9.75% -9.70% -14.25% -15.57% -10.61% -8.21% -4.96% -3.47%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -20.51% -16.74% -16.20% 0.00% -15.77% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.78 -12 -11 -8.04 -8.07 -11 -7.20 -7.74 -6.14 -3.65 -3.88
NOPAT Margin		 -6.85% -10.19% -8.07% -5.67% -5.43% -7.14% -4.43% -4.28% -3.19% -1.78% -1.69%
Net Nonoperating Expense Percent (NNEP)		 -10.23% 189.92% 21.39% 9.56% 7.53% 11.81% 28.67% 5.39% 3.46% 2.16% -2.99%
Return On Investment Capital (ROIC_SIMPLE)		 -1.43% - - - -1.35% -1.81% -1.20% -1.29% -1.02% -0.60% -0.42%
Cost of Revenue to Revenue		 61.70% 60.96% 60.12% 60.60% 60.27% 62.69% 59.90% 60.14% 60.90% 61.74% 61.99%
SG&A Expenses to Revenue		 11.27% 12.16% 12.43% 11.33% 11.77% 11.28% 10.42% 10.77% 9.80% 10.07% 10.78%
R&D to Revenue		 6.94% 7.82% 7.56% 6.59% 6.98% 7.40% 6.77% 6.93% 6.28% 5.57% 5.66%
Operating Expenses to Revenue		 48.09% 53.60% 51.41% 47.50% 47.49% 47.51% 46.43% 45.98% 43.67% 40.81% 40.43%
Earnings before Interest and Taxes (EBIT)		 -13 -18 -16 -12 -11 -16 -28 -13 -8.60 -5.68 -6.55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -9.63 -15 -12 -8.25 -7.36 -12 -23 -7.11 -3.02 -0.18 -0.15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.95 2.56 1.69 2.87 6.72 4.04 6.33 10.17 11.06 7.50 8.53
Price to Tangible Book Value (P/TBV)		 53.24 36.04 27.93 47.07 107.72 80.11 0.00 0.00 0.00 0.00 16.67
Price to Revenue (P/Rev)		 3.52 1.71 1.06 1.72 3.88 2.18 2.84 4.30 4.44 2.86 6.29
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.83 2.45 1.61 2.63 6.07 3.62 4.92 7.72 8.28 5.79 12.09
Enterprise Value to Revenue (EV/Rev)		 3.54 1.76 1.14 1.81 3.95 2.27 3.00 4.46 4.59 2.99 6.05
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 1,357.83 266.40 518.10 90.89 176.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.85 0.88 0.89 0.90 0.90 0.91 1.20 1.20 1.18 1.16 0.55
Long-Term Debt to Equity		 0.85 0.88 0.89 0.90 0.90 0.91 1.20 1.20 1.18 0.86 0.41
Financial Leverage		 -0.05 0.01 0.04 0.07 0.08 0.12 0.23 0.24 0.24 0.25 -0.11
Leverage Ratio		 2.05 2.07 2.10 2.11 2.15 2.19 2.32 2.34 2.34 2.41 2.01
Compound Leverage Factor		 1.77 1.89 1.86 1.80 1.90 2.02 2.22 2.14 2.18 2.12 1.52
Debt to Total Capital		 46.03% 46.74% 47.14% 47.23% 47.33% 47.74% 54.59% 54.49% 54.20% 53.67% 35.54%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.96% 9.24%
Long-Term Debt to Total Capital		 46.03% 46.74% 47.14% 47.23% 47.33% 47.74% 54.59% 54.49% 54.20% 39.71% 26.29%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.18% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.12%
Common Equity to Total Capital		 53.79% 53.07% 52.67% 52.58% 52.48% 52.07% 45.22% 45.32% 45.61% 46.14% 64.34%
Debt to EBITDA		 -4.51 -4.67 -4.78 -6.39 -6.75 -7.29 -6.55 -6.71 -7.38 -9.94 -31.43
Net Debt to EBITDA		 -0.14 -0.40 -0.64 -1.01 -0.95 -1.25 -1.94 -2.02 -2.35 -3.03 18.38
Long-Term Debt to EBITDA		 -4.51 -4.67 -4.78 -6.39 -6.75 -7.29 -6.55 -6.71 -7.38 -7.36 -23.25
Debt to NOPAT		 -5.47 -5.63 -6.86 -7.08 -7.22 -7.56 -9.58 -9.68 -10.28 -13.26 -15.34
Net Debt to NOPAT		 -0.17 -0.48 -0.91 -1.12 -1.01 -1.29 -2.83 -2.91 -3.27 -4.04 8.97
Long-Term Debt to NOPAT		 -5.47 -5.63 -6.86 -7.08 -7.22 -7.56 -9.58 -9.68 -10.28 -9.81 -11.35
Altman Z-Score		 3.02 1.71 1.28 1.92 3.91 2.38 2.81 4.33 4.78 3.19 7.28
Noncontrolling Interest Sharing Ratio		 0.31% 0.33% 0.34% 0.35% 0.35% 0.36% 0.39% 0.38% 0.38% 0.38% 0.26%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.28 4.34 4.64 4.59 4.38 3.74 3.91 3.62 3.76 1.78 3.21
Quick Ratio		 4.07 4.10 4.42 4.41 4.20 3.54 3.72 3.44 3.56 1.68 3.09
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -20 -16 -32 -32 -24 -25 -21 -18 -32 -27 -40
Operating Cash Flow to CapEx		 -20.15% -269.93% -210.48% -75.55% 200.24% -67.12% -6.13% 77.76% 42.96% 138.20% 21.82%
Free Cash Flow to Firm to Interest Expense		 -16.72 -13.38 -27.31 -27.04 -20.28 -20.71 -17.43 -13.90 -25.31 -21.58 -31.67
Operating Cash Flow to Interest Expense		 -1.09 -9.87 -7.66 -3.06 7.65 -3.11 -0.36 4.53 3.50 11.62 2.32
Operating Cash Flow Less CapEx to Interest Expense		 -6.50 -13.52 -11.30 -7.11 3.83 -7.74 -6.25 -1.30 -4.65 3.21 -8.31
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.64 0.68 0.72 0.76 0.79 0.83 0.88 0.93 0.99 1.04 0.93
Accounts Receivable Turnover		 7.76 7.91 7.81 7.37 7.57 7.41 7.65 7.25 8.02 7.22 7.44
Inventory Turnover		 127.98 135.66 145.48 132.85 97.03 101.06 97.91 100.82 106.71 117.89 116.22
Fixed Asset Turnover		 16.94 16.25 15.79 15.44 13.56 13.53 13.29 13.27 13.02 12.73 12.33
Accounts Payable Turnover		 10.13 22.35 26.82 32.44 8.36 10.89 14.07 14.83 10.49 8.00 8.79
Days Sales Outstanding (DSO)		 47.01 46.14 46.76 49.53 48.19 49.25 47.74 50.37 45.54 50.57 49.08
Days Inventory Outstanding (DIO)		 2.85 2.69 2.51 2.75 3.76 3.61 3.73 3.62 3.42 3.10 3.14
Days Payable Outstanding (DPO)		 36.04 16.33 13.61 11.25 43.65 33.50 25.94 24.60 34.78 45.63 41.55
Cash Conversion Cycle (CCC)		 13.82 32.49 35.66 41.02 8.31 19.36 25.53 29.39 14.18 8.03 10.67
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 339 346 355 361 355 360 368 371 381 383 404
Invested Capital Turnover		 1.39 1.40 1.46 1.50 1.57 1.63 1.67 1.75 1.86 1.99 2.09
Increase / (Decrease) in Invested Capital		 11 3.41 22 24 16 14 13 10 26 23 36
Enterprise Value (EV)		 1,640 846 572 952 2,155 1,303 1,810 2,866 3,153 2,218 4,886
Market Capitalization		 1,630 820 533 906 2,114 1,254 1,712 2,767 3,048 2,117 5,077
Book Value per Share		 $7.25 $6.60 $6.85 $6.39 $6.34 $6.16 $5.34 $5.35 $5.38 $5.44 $11.31
Tangible Book Value per Share		 $0.67 $0.47 $0.41 $0.39 $0.40 $0.31 ($0.47) ($0.42) ($0.33) ($0.18) $5.79
Total Capital		 612 604 600 600 599 595 598 600 604 611 925
Total Debt		 282 282 283 283 284 284 326 327 328 328 329
Total Long-Term Debt		 282 282 283 283 284 284 326 327 328 243 243
Net Debt		 8.88 24 38 45 40 49 97 98 104 100 -192
Capital Expenditures (CapEx)		 6.42 4.35 4.32 4.81 4.54 5.50 6.96 7.45 10 11 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.26 8.84 16 21 13 14 19 22 27 21 32
Debt-free Net Working Capital (DFNWC)		 273 263 257 255 253 245 244 247 246 245 549
Net Working Capital (NWC)		 273 263 257 255 253 245 244 247 246 160 463
Net Nonoperating Expense (NNE)		 1.78 4.10 3.00 2.16 1.83 4.30 19 3.86 2.49 1.61 1.43
Net Nonoperating Obligations (NNO)		 8.88 24 38 45 40 49 97 98 104 100 -192
Total Depreciation and Amortization (D&A)		 3.26 3.62 3.72 3.68 3.86 4.71 4.97 5.59 5.58 5.50 6.41
Debt-free, Cash-free Net Working Capital to Revenue		 0.92% 1.84% 3.18% 3.96% 2.37% 2.41% 3.10% 3.49% 3.87% 2.84% 3.96%
Debt-free Net Working Capital to Revenue		 58.92% 54.63% 51.14% 48.52% 46.33% 42.73% 40.49% 38.42% 35.78% 33.07% 67.95%
Net Working Capital to Revenue		 58.92% 54.63% 51.14% 48.52% 46.33% 42.73% 40.49% 38.42% 35.78% 21.55% 57.36%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.64) ($0.34) ($0.28) ($0.21) ($1.23) ($0.30) ($0.52) ($0.23) ($0.17) ($0.10) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding		 95.83M 48.58M 48.84M 49.28M 98.17M 50.34M 50.70M 50.92M 50.81M 51.91M 54.22M
Adjusted Diluted Earnings per Share		 ($1.64) ($0.34) ($0.28) ($0.21) ($1.23) ($0.30) ($0.52) ($0.23) ($0.17) ($0.10) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding		 95.83M 48.58M 48.84M 49.28M 98.17M 50.34M 50.70M 50.92M 50.81M 51.91M 54.22M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.58M 46.12M 49.30M 49.56M 50.30M 50.68M 50.80M 51.25M 51.82M 52.60M 57.32M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.78 -12 -11 -8.04 -8.01 -11 -7.20 -7.71 -6.14 -3.65 -3.88
Normalized NOPAT Margin		 -6.85% -10.19% -8.07% -5.67% -5.39% -7.14% -4.43% -4.26% -3.19% -1.78% -1.69%
Pre Tax Income Margin		 -8.67% -13.53% -10.34% -7.18% -6.69% -9.99% -16.27% -6.43% -4.17% -2.44% -2.16%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -10.85 -15.34 -13.07 -10.05 -9.44 -13.70 -23.40 -9.93 -6.83 -4.52 -5.21
NOPAT to Interest Expense		 -7.39 -10.51 -9.01 -6.77 -6.79 -9.07 -6.09 -6.06 -4.88 -2.90 -3.09
EBIT Less CapEx to Interest Expense		 -16.26 -19.00 -16.71 -14.10 -13.26 -18.32 -29.29 -15.76 -14.99 -12.93 -15.85
NOPAT Less CapEx to Interest Expense		 -12.79 -14.17 -12.65 -10.82 -10.61 -13.70 -11.98 -11.89 -13.04 -11.32 -13.72
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -13.12% -12.82% -13.09% 0.00% -1.02%

Financials Breakdown Chart

Key Financial Trends

Xometry’s financial profile is improving operationally, but the company remains unprofitable and relies partly on financing and noncash adjustments to support cash generation. Revenue reached $229.3 million in Q2 2026, up 11.8% from $205.1 million in Q1 2026 and 41.1% from $162.5 million in Q2 2025. Compared with Q2 2023, revenue has more than doubled.

  • Strong revenue growth: Quarterly revenue increased from $103.6 million in Q3 2022 to $229.3 million in Q2 2026. The latest quarter also represented the highest revenue level in the provided data set.
  • Narrowing operating losses: The operating loss improved to $5.5 million in Q2 2026 from $10.3 million in Q2 2025 and $28.1 million in Q2 2023. Operating expenses grew more slowly than revenue over the longer period, indicating improving operating leverage.
  • Improved bottom-line results: Net loss attributable to common shareholders narrowed to $5.3 million in Q2 2026 from $26.4 million in Q2 2025 and $26.6 million in Q2 2023. The loss per share improved to $0.10 from $0.52 in Q2 2025.
  • Positive operating cash flow in recent quarters: Cash from operating activities was $2.9 million in Q2 2026, following $14.6 million in Q1 2026, $4.4 million in Q4 2025 and $5.8 million in Q3 2025. This is a notable improvement from operating cash outflows in Q1 and Q2 2025.
  • Substantial liquidity: Cash and short-term investments totaled approximately $515.6 million at the end of Q2 2026, up from roughly $286.1 million at the end of Q2 2025. Current assets of $672.4 million were more than three times current liabilities of $209.2 million.
  • Interest income provides support: Interest and investment income increased to $2.9 million in Q2 2026 from $1.9 million in Q1 2026, helping offset a portion of interest expense and reducing the company’s reliance on operating profitability in the near term.

Despite better growth and cash-flow trends, Xometry’s gross margin was approximately 38.0% in Q2 2026, down from 40.0% in Q2 2025 and 39.2% in Q2 2023. Marketing expense was $33.6 million, or about 14.7% of revenue, while total operating expenses remained above gross profit. As a result, the company has not yet reached operating or net profitability.

  • Investing activity was unusually large: Xometry purchased $314.5 million of investments in Q2 2026 and reported $303.2 million of financing cash inflow. The resulting increase in liquidity largely reflects portfolio and financing activity rather than internally generated cash.
  • Capital investment is increasing: Purchases of property, plant and equipment rose to $13.4 million in Q2 2026 from $10.6 million in Q1 2026 and $7.4 million in Q3 2025. This may support future growth, but it also raises the cash required to reach sustainable free cash flow.
  • Receivables are growing with revenue: Accounts receivable increased to $130.3 million from $119.7 million in Q1 2026 and $86.9 million in Q2 2025. The increase is consistent with higher sales, but investors should monitor collections and working-capital efficiency.
  • Persistent net losses: Xometry has reported a net loss in every quarter presented, including a $5.3 million loss in Q2 2026. Retained earnings remained deeply negative at approximately $442.6 million.
  • Debt remains significant: Short- and long-term debt totaled approximately $328.7 million at the end of Q2 2026. Although liquidity exceeds debt when short-term investments are included, interest expense continues to reduce earnings.
  • Recent financing inflow may indicate dilution or increased funding dependence: The $303.2 million financing inflow in Q2 2026 coincided with common stock of $1.04 billion, compared with $723.3 million in Q1 2026. Basic weighted-average shares increased to 54.2 million from 51.9 million in Q1 2026 and 50.7 million in Q2 2025, which could dilute existing shareholders.
  • Cash generation is not yet consistently self-funded: Although operating cash flow turned positive in recent quarters, Q2 2026 operating cash flow was only $2.9 million against $13.4 million of capital expenditures. The company therefore remained free-cash-flow negative for the quarter before considering investment transactions.
  • Goodwill creates balance-sheet risk: Goodwill was approximately $263.5 million, or nearly 25% of total assets, at the end of Q2 2026. A deterioration in acquired businesses could lead to impairment charges and further pressure equity.

Overall, the trend is constructive but incomplete. Xometry is growing rapidly, losses are narrowing, and operating cash flow has recently turned positive. However, declining gross margins, continued net losses, sizable debt, rising share counts and dependence on financing activity remain important risks. Investors should focus on whether revenue growth can translate into sustained operating profitability and free cash flow without additional shareholder dilution.

09/19/26 01:31 PM ETAI Generated. May Contain Errors.

Xometry Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xometry's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Xometry's net income appears to be on an upward trend, with a most recent value of -$61.75 million in 2025, rising from -$30.99 million in 2019. The previous period was -$50.40 million in 2024. Find out what analysts predict for Xometry in the coming months.

Xometry's total operating income in 2025 was -$45.52 million, based on the following breakdown:
  • Total Gross Profit: $268.77 million
  • Total Operating Expenses: $314.29 million

Over the last 6 years, Xometry's total revenue changed from $80.23 million in 2019 to $686.63 million in 2025, a change of 755.8%.

Xometry's total liabilities were at $426.98 million at the end of 2025, a 17.1% increase from 2024, and a 981.0% increase since 2020.

In the past 5 years, Xometry's cash and equivalents has ranged from $15.00 million in 2025 to $86.26 million in 2021, and is currently $15.00 million as of their latest financial filing in 2025.

Over the last 6 years, Xometry's book value per share changed from 0.00 in 2019 to 5.38 in 2025, a change of 537.8%.


Related Companies

Financial statements for NASDAQ:XMTR last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel